Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens

Sunwen Chou, Gail I. Marousek, Laura C. Van Wechel, Shaobing Li, Adriana Weinberg

Research output: Contribution to journalArticle

43 Scopus citations


Recombinant phenotyping of cytomegalovirus (CMV) pol region III mutations from clinical specimens showed that T813S and G841A each conferred foscarnet resistance and approximately threefold increased ganciclovir resistance; adding the UL97 mutation C592G increased ganciclovir resistance to approximately sixfold. Bacterial artificial chromosome CMV clones containing pol mutation L845P were nonviable unless repaired with the wild-type sequence.

Original languageEnglish (US)
Pages (from-to)4160-4162
Number of pages3
JournalAntimicrobial agents and chemotherapy
Issue number11
StatePublished - Nov 1 2007


ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this